James V. Freeman retweeted
Live from Frankfurt 🇩🇪 Complex LAAC takes center stage during this Operator’s Choice case performed by Dr. Horst Sievert.
#NYValves2026 #LAACatNYValves #CardioX #CardioTwitter #CardioEd #CardioResearch @SDoshiMD @jfreeMD @DrGarot @AGoldsweig @RPHortonMD @OkhaliqueMD @MartyBLeon @drdevignair @matthewjpricemd @Vivekreddymd @docsaw @jgranadacrf @triciarawh @TCTConference @TCTMD @Dr_ibrahimHarbi @CathWhisperer @caldera_99 @aelsab @mderdem3 @CAESmedmd @NadeenFaza @RaghavG_MD @evandrofilhobr @GiorgioMedranda @purviparwani @SaadUrRahman55 @LucySafi @ShariqShamimMD @Sticchi_Alex @ladyheart_md
James V. Freeman retweeted
Atrial Fibrillation Ablation Energy Source Transition and Adjunctive Lesion Set Utilization After Commercial Release of Pulse Field Ablation
@DanFriedmanMD @jfreeMD
heartrhythmjournal.com/artic…
James V. Freeman retweeted
Incidence of Atrial Fibrillation in Pacemaker Patients with Left Bundle Branch Area Pacing Versus Right Ventricular Pacing Leads
@DanFriedmanMD @jfreeMD
heartrhythmjournal.com/artic…
Really important study using @Pacemate data. Loop recorders have variable performance with real clinical implications. More to come!
Not all loop recorders are equal - our analysis using @Pacemate data. Important to select based on indication and patient #ReducingAlertBurden
#CHRD @adelaideuni
Manuscript: authors.elsevier.com/a/1mc2p…
It was an incredible pleasure to join @nmarrouche @westernAFib last week. Incredible content and great opportunity to learn from some of the best in the business.
What a pleasure it was to visit @UofUCV last week.
This week in Grand Rounds we’re closing the gap on AFib care! 📈
Don’t miss Dr. James V. Freeman (@jfreeMD) from @YaleCardiology this Friday, Feb 27!
📍 HELIX Canyon Maple (3C115)
🕛 12:00 PM MT
#EPeeps #AFib #GrandRounds
James V. Freeman retweeted
Concomitant Farapulse and Watchman FLX Pro Workflow - live cases continue at #WAFIB2026! @westernAFib @nmarrouche @Drdevignair @omwazni @jfreeMD
James V. Freeman retweeted
Replying to @jfreeMD
@jfreeMD discusses managing atrial fibrillation in patients with heart failure during this presentation for the #AHFTC lecture series. @YaleHF @YaleCardiology
youtu.be/AG1N5MwXZGs?si=znNM…
Nice review on the topic. Wishful thinking that AF is won’t recur for many.
This Post is from a suspended account. Learn more
Congratulations Andrea!
Congratulations to Andrea Natale, MD, FHRS, winner of the 2025 Wilton Wells Webster Lectureship Award at #HRS2025. His lectureship was titled "Innovations in the Advancement of Care in Patients with AF in the Last 3 Decades: A Chronicle of My Journey." #EPeeps #LectureshipAward
Our study showing resource utilization and cost of care increase substantially with AF in patients with symptomatic obstructive HCM.
Atrial fibrillation adds substantially to the economic burden in patients with symptomatic obstructive hypertrophic cardiomyopathy. #AHAJournals @jfreeMD ahajrnls.org/4mMeHoJ
Always a joy to work with @jeffrey_vinocur. Pushing the field of ACHD arrhythmia treatment. @YaleCardiology
Our study showing that rates of stroke after LAAO remain steady over long term 5- year follow-up demonstrating the durable effectiveness of the therapy.
Long term #stroke outcomes in Medicare patients after LAAO are low and similar to randomized trial data. #AHAJournals @jfreeMD ahajrnls.org/4oOnZSr
James V. Freeman retweeted
🚨 New in Heart Rhythm: This is BIG
ICD battery longevity varies by 2–3 years depending on manufacturer and number of leads.
🔋 Newer devices last 2–4 years longer.
📉 Each additional lead = 2–3 yrs less battery life.
📈 Key drivers: manufacturer, pulse width, output.
We need to select our devices carefully - data from a large remote monitoring service
📄 doi: 10.1016/j.hrthm.2025.05.031
#EPeeps #Cardiology #ICD #DigitalHealth
Really fun to discuss all things LAAO at #NYValves2025. Great all day summit. @SDoshiMD @Drdevignair
James V. Freeman retweeted
There are few in this world who were such forces for good as @atulbutte. His dazzling intellect, relentless curiosity, generosity of spirit, boundless charisma, and infinite optimism left a mark on everything he touched and everyone lucky enough to know him. An enormous loss.
James V. Freeman retweeted
Association of Chronic Kidney Disease and Kidney Failure with Replacement Therapy with Procedural and Long-Term Outcomes after First Generation Watchman Device: Insights from the NCDR LAAO Registry
@drbilalmunirm @jfreeMD
heartrhythmjournal.com/artic…
This is when MAUDE really serves a vital role. Early surveillance for safety issues. Nice study.
Post-market surveillance for the EV ICD system, collected from the MAUDE database, shows a number of complications not previously seen #AHAJournals @rranjanMD @shah-in-boots @tjaredbunch doi.org/10.1161/CIRCEP.125.0…
James V. Freeman retweeted
Post-market surveillance for the EV ICD system, collected from the MAUDE database, shows a number of complications not previously seen #AHAJournals @rranjanMD @shah-in-boots @tjaredbunch doi.org/10.1161/CIRCEP.125.0…
Excited to publish our study on ICD battery longevity in @hrs_journal. Each additional lead costs 2-3 years of longevity, newer devices have an additional 2-4 years of longevity for all manufacturers. And yes- there are real differences by manufacturer!
Variability in Implantable Cardioverter-Defibrillator Battery Longevity
@jfreeMD @ba_steinberg
heartrhythmjournal.com/artic…
































